| Identification | Back Directory | [Name]
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-methyl-1,4-dithiin-2-yl)-, 3,5-bis(4-pyridinylmethyl) ester | [CAS]
1000817-20-8 | [Synonyms]
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-methyl-1,4-dithiin-2-yl)-, 3,5-bis(4-pyridinylmethyl) ester | [Molecular Formula]
C26H25N3O4S2 | [MOL File]
1000817-20-8.mol | [Molecular Weight]
507.62 |
| Hazard Information | Back Directory | [Description]
NIK-250 is a P-glycoprotein inhibitor. NIK250 might be useful in reversing MDR, which often develops during chemotherapy of advanced or hormone-resistant prostatic cancer. NIK250 could also reverse multidrug resistance in human glioma cells. The glioma cell lines were the two MRP-expressing cell lines, T98G and IN500, an MDR1-expressing cell line, CCF-STTG1, and the MRP1 MDR1-non-expressing cell line, IN157. |
|
|